We estimate that the CEO of PROCEPT BioRobotics Corp ($PRCT), Larry L. Wood, received a compensation of $15,074,745 in 2025.
These estimates are based on a new DEF14A filing, filed with the SEC on April 22, 2026. Note that parsing errors may occur.
You can track $PRCT on Quiver Quantitative's $PRCT stock dashboard.
$PRCT Stock Insider Trading Activity
$PRCT Stock insiders have traded $PRCT stock on the open market 13 times in the past 6 months. Of those trades, 7 have been purchases and 6 have been sales.
Here’s a breakdown of recent trading of $PRCT stock by insiders over the last 6 months:
- ANTAL ROHIT DESAI has made 7 purchases buying 426,262 shares for an estimated $10,482,942 and 0 sales.
- ALALEH NOURI (EVP, CLO, CORP. SEC.) has made 0 purchases and 4 sales selling 12,559 shares for an estimated $311,142.
- KEVIN WATERS (EVP, CFO) has made 0 purchases and 2 sales selling 7,427 shares for an estimated $179,176.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$PRCT Stock Hedge Fund Activity
We have seen 161 institutional investors add shares of $PRCT Stock stock to their portfolio, and 104 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC removed 3,382,944 shares (-42.1%) from their portfolio in Q4 2025, for an estimated $106,427,418
- BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. added 2,002,389 shares (+183.3%) to their portfolio in Q4 2025, for an estimated $62,995,157
- WESTFIELD CAPITAL MANAGEMENT CO LP removed 1,970,147 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $61,980,824
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 1,667,045 shares (-81.2%) from their portfolio in Q4 2025, for an estimated $52,445,235
- PROSIGHT MANAGEMENT, LP added 1,303,009 shares (+1692.4%) to their portfolio in Q4 2025, for an estimated $40,992,663
- LOOMIS SAYLES & CO L P removed 983,903 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $30,953,588
- JPMORGAN CHASE & CO removed 560,785 shares (-92.2%) from their portfolio in Q4 2025, for an estimated $17,642,296
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$PRCT Stock Analyst Ratings
Wall Street analysts have issued reports on $PRCT in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Truist Securities issued a "Buy" rating on 12/18/2025
- UBS issued a "Buy" rating on 12/12/2025
- TD Cowen issued a "Buy" rating on 11/05/2025
To track analyst ratings and price targets for $PRCT Stock, check out Quiver Quantitative's $PRCT forecast page.
$PRCT Stock Price Targets
Multiple analysts have issued price targets for $PRCT recently. We have seen 9 analysts offer price targets for $PRCT in the last 6 months, with a median target of $30.0.
Here are some recent targets:
- David Rescott from Baird set a target price of $30.0 on 03/06/2026
- Richard Newitter from Truist Securities set a target price of $30.0 on 03/02/2026
- Craig Bijou from B of A Securities set a target price of $20.0 on 02/26/2026
- Nathan Treybeck from Wells Fargo set a target price of $34.0 on 02/26/2026
- Joshua Jennings from TD Cowen set a target price of $34.0 on 02/26/2026
- Matt O'Brien from Piper Sandler set a target price of $28.0 on 02/26/2026
- Mike Kratky from Leerink Partners set a target price of $30.0 on 02/26/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
